Answers are grounded in this paper and cite their sources.
Inhibition of potassium chloride cotransporters reduced contractility and increased muscle atrophy in C2C12 myotubes, suggesting implications for muscle disorders.
In skeletal muscle cells, the resting membrane potential is primarily determined by Cl−, necessitating precise regulation of intracellular and extracellular Cl− balance. Potassium chloride cotransporters (KCCs), members of the cation-chloride cotransporter superfamily, facilitate the efflux of K+ and Cl− at a 1:1 ratio. However, the specific roles of KCCs in skeletal muscle remain poorly understood. In this study, we investigated the function of KCCs in skeletal muscle cells using [(dihydroindenyl)oxy]acetic acid (DIOA), a KCCs inhibitor. DIOA treatment of cultured C2C12 myotubes impaired contractility in response to electrical pulse stimulation. Additionally, DIOA-treated myotubes exhibited muscle atrophy, accompanied by increased expression of atrogenes such as Atrogin-1 and MuRF1. These findings reveal a novel role for KCCs in skeletal muscle and provide insights that may contribute to the development of preventive or therapeutic strategies for muscle disorders and atrophy.
No takes yet. Share an insight, caveat, or question.
Kimura et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: